论文部分内容阅读
目的了解辽宁省沈阳市呼吸道合胞病毒肺炎住院患儿的药物使用情况,为进一步评价临床合理用药提供参考依据。方法收集沈阳市某4所三级甲等医院2012年3月—2014年9月收治的372例≤6周岁呼吸道合胞病毒肺炎住院患儿的病历资料,分析其药物使用情况。结果 372例呼吸道合胞病毒肺炎住院患儿中,抗菌药物使用率为97.33%,抗病毒药物使用率为54.84%;患儿共使用抗菌药物32种、抗病毒药物9种,合计7类药物1 254例次,其中使用头孢菌素类抗菌药物608例次,占48.5%;使用抗病毒类药物258例次,占20.6%;使用大环内酯类抗菌药物183例次,占14.6%;使用青霉素类抗菌药物139例次,占11.1%;使用氨基苷类抗菌药物35例次,占2.8%;使用磺胺类抗菌药物30例次,占2.4%;使用喹诺酮类抗菌药物1例次,占0.1%。结论沈阳市呼吸道合胞病毒肺炎住院患儿以使用抗菌药物治疗为主,抗病毒药物使用不足。
Objective To understand the use of drugs in hospitalized children with respiratory syncytial virus pneumonia in Shenyang, Liaoning Province, and to provide a reference for further evaluation of clinical rational drug use. Methods A total of 372 hospitalized children with respiratory syncytial virus pneumonia ≤6 years of age from March 2012 to September 2014 in Shenyang were collected and their medical conditions were analyzed. Results Among the 372 hospitalized children with respiratory syncytial virus pneumonia, the antibacterial drug use rate was 97.33% and the antiviral drug use rate was 54.84%. There were 32 antibacterial drugs, 9 antiviral drugs and 7 drugs in total 254 cases, of which 608 cases were cephalosporin antibiotics, accounting for 48.5%; 258 cases were anti-virus drugs, accounting for 20.6%; 183 cases were macrolide antibiotics, accounting for 14.6% Penicillins antibiotics 139 cases, accounting for 11.1%; use of aminoglycoside antibiotics in 35 cases, accounting for 2.8%; use of sulfa antibiotics 30 cases, accounting for 2.4%; quinolone antibiotics 1 case times, accounting for 0.1 %. Conclusion Inpatients with respiratory syncytial virus pneumonia in Shenyang are mainly treated with antimicrobial drugs, and the use of antiviral drugs is insufficient.